Italian Authorities Ban Nicotine Pouches Supply and Display

Mar.15.2023

Italian Authorities Ban Nicotine Pouches Supply and Display

Italian customs has ordered retailers to cease supplying nicotine pouches due to health concerns.

Recently, the Italian Customs and Monopolies Agency (ADM) issued an order to all retailers and trade associations in the country, instructing them to suspend the supply of nicotine pouches.

It is reported that the Ministry of Health has conducted a sampling investigation on some nicotine pouches available in the market to analyze their potential dangers. During this investigation, businesses are prohibited from displaying the products or samples of nicotine pouches. The specific release time will be notified separately.

References:

Adm formalizes the ban on the supply and display of nicotine pouches in the sales network.

#Legislation #Asia #China #Disposable e-cigarettes #Nicotine pouches #Nicotine e-cigarettes #Nicotine-containing e-cigarettes

This document has been generated through artificial intelligence translation and is provided solely for the purposes of industry discourse and learning. Please note that the intellectual property rights of the content belong to the original media source or author. Owing to certain limitations in the translation process, there may be discrepancies between the translated text and the original content. We recommend referring to the original source for complete accuracy. In case of any inaccuracies, we invite you to reach out to us with corrections. If you believe any content has infringed upon your rights, please contact us immediately for its removal.

China Tobacco Regulation Shift：Policy Updates and Market Impact

China Tobacco Regulation Shift：Policy Updates and Market Impact

Ireland’s HSE finds over a fifth of vape shops tested still selling to children despite under-18 ban

Ireland’s HSE finds over a fifth of vape shops tested still selling to children despite under-18 ban

Ireland’s Health Service Executive (HSE) data show that more than a fifth of vape shops tested were still selling nicotine-inhaling vaping products to children, despite a ban on sales to under-18s that took effect on December 22, 2023.

Jan.05 by 2FIRSTS.ai

Türkiye’s trade minister: valued at USD 40 million in illicit e-cigarette products seized over five years

Türkiye’s trade minister: valued at USD 40 million in illicit e-cigarette products seized over five years

Türkiye’s Trade Minister Ömer Bolat said that over the past five years, authorities carried out 4,589 operations seizing 28,683,985 e-cigarette devices and parts and 1,070,586 grams/ml of e-liquid, valued at TL 1,762,796,000 (about USD 40,544,308).

Jan.20 by 2FIRSTS.ai

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Group (Nasdaq: XXII) reported early commercial momentum for its FDA-authorized VLN® very low nicotine cigarettes, distributing approximately 8,800 cartons across 1,700 new U.S. retail outlets in the fourth quarter of 2025, while forecasting expansion to more than 5,000 retail points in 2026.

Russian's Stavropol court convicts four men over illegal sales of disposable vapes

Russian's Stavropol court convicts four men over illegal sales of disposable vapes

A court in Russia’s Stavropol region convicted four local residents of illegal sales of disposable vapes, with the seized products valued at more than 26 million rubles (about $338,000). The regional prosecutor’s office said the organized group operated from March 2022 to June 2023, selling disposable electronic vapes in Stavropol, Nevinnomyssk and Mikhaylovsk, while the products lacked mandatory information required by law.

Dec.31 by 2FIRSTS.ai

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

At the third session of its PMTA roundtable, the FDA outlined its framework for assessing abuse liability in ENDS products, emphasizing the role of nicotine pharmacokinetics and product-specific data in APPH determinations. Small manufacturers questioned the high cost of clinical PK studies and the absence of defined numeric thresholds, while raising bridging strategies and PBPK modeling as potential alternatives.

Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%

Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%

Ispire reported a sharp year-on-year revenue decline in Q2 FY2026 as it shifted away from lower-quality customers, while cutting operating expenses and narrowing its net loss. The company also highlighted improved collections, with net accounts receivable down nearly one-fifth since June 30, 2025, alongside ongoing manufacturing and technology initiatives.

Feb.09 by 2FIRSTS.ai

Related Topics

News

Related Read

Ireland’s HSE finds over a fifth of vape shops tested still selling to children despite under-18 ban

Ireland’s HSE finds over a fifth of vape shops tested still selling to children despite under-18 ban

Türkiye’s trade minister: valued at USD 40 million in illicit e-cigarette products seized over five years

Türkiye’s trade minister: valued at USD 40 million in illicit e-cigarette products seized over five years

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

22nd Century Positions VLN® Cigarettes for Growth as FDA Considers 0.7 mg/g Nicotine Cap

Russian's Stavropol court convicts four men over illegal sales of disposable vapes

Russian's Stavropol court convicts four men over illegal sales of disposable vapes

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Small ENDS Manufacturers Press FDA on Abuse Liability Standards as Agency Defines Pharmacological Review Framework

Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%

Ispire Q2 FY2026 revenue falls to $20.3M as it trims lower-quality customers; A/R down nearly 20%